Table 1.
Surface protein | Manufacturer | hASC expression (mean ± SD) | oASC expression (mean ± SD) |
---|---|---|---|
CD14 | BD | 5.4 | 8.0 ± 2.4 |
CD19 | BD | 1.5 | 1.2 ± 0.1 |
CD34 | IT | 4.3 ± 0.9 | 23.6 ± 14.5 |
CD45 | BD | 1.1 ± 1.2 | 9.3 ± 4.2 |
CD105 | RD | 87.3 ± 11.4 | 30.3 ± 7.2 |
CD117 | MB | Not analyzed | 0.5 ± 0 |
HLA-DR | IT | 0.5 | 1.8 ± 0.3 |
BD: BD Biosciences, Erembodegem, Belgium; IT: Immunotools GmbH Friesoythe, Germany; RD: R&D Systems Inc., Minn, USA; MB: Miltenyi Biotech, Bergisch Gladbach, Germany; Sigma: Sigma, St. Louis, Mo, USA; HLA-DR, major histocompatibility class II antigen.